Press release
Future of Glucagon-like Peptide 1 Market: Size, Share & Forecasts to 2029
Glucagon-like Peptide 1 Market
What Is the Projected Market Size Valuation of the Glucagon-like Peptide 1 Market by 2025?
The market size of glucagon-like peptide 1 has experienced a robust growth in the past few years. It is projected to increase from $20.88 billion in 2024 to $22.06 billion in 2025, progressing at a compound annual growth rate (CAGR) of 5.7%. Growth factors during the historic period include the escalating occurrence of diabetes, intensified focus on superior diabetes management, patient's inclination towards injectable treatments, clinical effectiveness and safety parameters, as well as advancements made in diabetes research.
What Is the Estimated Market Growth Value for the Glucagon-like Peptide 1 Industry in 2029?
In the coming years, the glucagon-like peptide 1 market is projected to experience robust expansion, reaching an estimated value of $30.5 billion by 2029, with a compound annual growth rate (CAGR) of 8.4%. The predicted growth within this period is due to the introduction of oral glp-1 treatments, emphasis on personalized healthcare, incorporation in diabetes management protocols, and a focus on patient-oriented healthcare strategies. In the forecast period, key trends include market outreach in developing economies, approval of new formulations by regulations, an increased concentration on personalized healthcare, enhancement of patient knowledge through educational and awareness programs, and dynamics of competitive market landscape.
Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/glucagon-like-peptide-1-global-market-report
What Are the Growth Drivers and Opportunities in the Glucagon-like Peptide 1 Market?
The upward trend in diabetes prevalence is predicted to boost the worldwide market for glucagon-like peptide 1. Diabetes is a health condition characterized by high levels of blood glucose or sugar. Glucagon-like peptide 1 is a prescribed medication for conditions such as type 2 diabetes, potentially aiding weight loss and lowering blood sugar levels. To illustrate, the National Library of Medicine, a US hub for biomedical informatics and computational biology, estimated in January 2022 that the global prevalence of diabetes in individuals aged between 20-79 was 10.5% (536.6 million people) in 2021, with forecasts showing an increase to 12.2% (783.2 million) by 2045. Hence, the rising incidence of diabetes is set to stimulate the glucagon-like peptide 1 market.
Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10830&type=smp
What Are the Primary Segments Covered in the Global Glucagon-like Peptide 1 Market Report?
The glucagon-like peptide 1 market covered in this report is segmented -
1) By Product: Trulicity, Ozempic, Victoza, Rybelsus, Other Types
2) By Route of Administration: Oral, Parenteral, Other Routes
3) By End-Users: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Trulicity: Injection (pre-filled pen), Dosage forms (0.75 mg, 1.5 mg, etc.)
2) By Ozempic: Injection (pre-filled pen), Dosage forms (0.5 mg, 1 mg, etc.)
3) By Victoza: Injection (pre-filled pen), Dosage forms (1.2 mg, 1.8 mg, etc.)
4) By Rybelsus: Oral tablet (3 mg, 7 mg, 14 mg)
5) By Other Types: Experimental formulations, Combination products with other medications, Alternative delivery systems
What Are the Top Growth Trends in the Glucagon-like Peptide 1 Market?
The surge in technological advancement is a significant trend taking over the global glucagon-like peptide 1 market. To retain their foothold in the market, leading companies are introducing groundbreaking technologies. For example, Novo Nordisk A/S, the acclaimed pharmaceutical company based in Denmark, introduced Wegovy in March 2024. This is the solitary, once-weekly glucagon-like peptide 1 treatment meant for weight control. Wegovy emerged successful and was proven safe and well-tolerated in the STEP Phase 3a clinical trial program. The product assists individuals dealing with obesity in attaining and sustaining weight reduction.
Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=10830&type=smp
Which Companies Are Shaping the Future of the Glucagon-like Peptide 1 Market?
Major companies operating in the glucagon-like peptide 1 market include Novo Nordisk AS, Sanofi SA, Eli Lilly and Co, AstraZeneca plc, Pfizer Inc, Boehringer Ingelheim International GmbH, F Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Baxter, Hikma Pharmaceuticals plc, Zealand Pharma A/S, Intarcia Therapeutics Inc., GlaxoSmithKline plc, Jiangsu Hansoh Pharmaceutical Group Co Ltd, Shanghai Benemae Pharmaceutical Corporation, Adocia, Biocon, Hanmi Pharmaceutical Co Ltd, Ligand Pharmaceuticals Incorporated, Advinus Therapeutics Ltd, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd, Union Chimique Belge, Amylin Pharmaceuticals LLC, Academic Pharmaceuticals Inc, ConjuChem Biotechnologies, MannKind Corporation:, Provention Bio Inc, Regeneron Pharmaceuticals
Which Region Holds the Largest Market Share in the Glucagon-like Peptide 1 Industry?
North America was the largest region in the glucagon-like peptide 1 market in 2024. The regions covered in the glucagon-like peptide 1 market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Future of Glucagon-like Peptide 1 Market: Size, Share & Forecasts to 2029 here
News-ID: 4159852 • Views: …
More Releases from The Business Research Company
Micropropagation Market Report 2026 Market Outlook Supported By A Forecast 9% CA …
The micropropagation market is gaining significant attention as a vital method for plant multiplication and cultivation. With the growing demand for sustainable agriculture and technological advances, this sector is on track for substantial growth. Let's explore the market size, emerging players, key trends, and segmentation that define the micropropagation industry today.
Projected Growth and Market Size of the Micropropagation Market
The micropropagation market is set to experience robust expansion over…
Microbiology And Bacterial Culture Media Market Insights Highlight Segment Expan …
The microbiology and bacterial culture media market is poised for significant expansion as it continues to play a vital role in healthcare, research, and industrial sectors. With evolving technologies and increasing demand for efficient microbial testing, this market is set to witness substantial growth and innovation by 2030.
Projected Growth and Market Size in the Microbiology and Bacterial Culture Media Market
Forecasts indicate that the microbiology and bacterial culture media…
Microbial Identification Market Report Evaluates Growth Drivers, Challenges And …
The microbial identification market is set to experience substantial expansion over the coming years, driven by cutting-edge technological advancements and increasing demand across various industries. With the integration of innovative tools and methodologies, this sector is poised to reach impressive milestones by 2030. Let's explore the market's size, key players, emerging trends, and segmentation to gain a clearer understanding of its future prospects.
Market Size and Growth Expectations in the Microbial…
Micro Computed Tomography Market Report Provides Insights Into Market Evolution …
The micro computed tomography market is on track for substantial expansion in the coming years, driven by technological advancements and a broadening range of applications. As industries and research fields increasingly embrace this imaging technology, the market is poised for significant growth and innovation through 2030.
Expected Market Size and Growth Trajectory of the Micro Computed Tomography Market
The micro computed tomography market is projected to reach a value of…
More Releases for Peptide
Peptide Companies Reviewed Launches Independent Resource to Help Readers Compare …
The educational platform introduces a structured review methodology focused on transparency, documentation, testing standards, and fulfillment practices to help readers evaluate research peptide suppliers with greater confidence.
Los Angeles, CA - August 17, 2026 - Peptide Companies Reviewed has launched an independent online resource designed to help readers compare research peptide suppliers using consistent editorial standards and publicly available information. The platform provides educational reviews and research guides that focus on…
Peptide Pod Launches a New Platform Bringing Peptide Podcasts and Research Toget …
The world's first dedicated peptide podcast platform brings trusted education, research, and leading voices together in one place.
United States - August 10, 2026 - As interest in peptides continues to rise, finding trustworthy educational content has become increasingly difficult. New podcasts, research papers, and online discussions appear almost daily, leaving many people searching across multiple websites to stay informed. Peptide Pod [https://peptidepod.com/] is changing that by bringing peptide podcasts, research,…
Automated Microwave Peptide Synthesizer Market Innovation: Accelerating High-Thr …
The global Automated Microwave Peptide Synthesizer Market is witnessing robust growth as pharmaceutical companies, biotechnology firms, and research organizations increasingly adopt automated peptide synthesis technologies to accelerate drug discovery and development. Automated microwave peptide synthesizers have transformed peptide manufacturing by significantly reducing synthesis time while improving reaction efficiency, reproducibility, and product quality. As peptide-based therapeutics continue gaining prominence across modern medicine, demand for advanced synthesis platforms is expanding rapidly.
According to…
Peptide Express Launches Independently HPLC-Verified Research Peptide Catalog
Peptide Express has launched an expanded catalog of 30+ research-grade peptides, each independently tested by third-party laboratories for 99%+ purity.
United States, 13th Jul 2026 - Peptide Express has announced the launch of its expanded catalog of research-grade peptides, built for laboratories, academic institutions, and independent researchers who require verifiable documentation of compound identity and purity.
The platform gives researchers access to more than 30 research compounds, each independently tested by third-party…
Peptide Dropshipping & White Label Peptide Fulfillment Solution Launch | RapidFu …
Image: https://www.globalnewslines.com/uploads/2026/04/a6b799d3d1fc2ae063a8a0793dc74785.jpg
Los Angeles, CA - April 16, 2026 - RapidFulfillment.com, a leading 3PL fulfillment provider, today announced the launch of its Peptide Dropshipping Service Partnership, a turnkey white label peptide fulfillment solution designed to help entrepreneurs, eCommerce brands, and B2B operators enter the rapidly growing peptide market-without inventory, infrastructure, or operational complexity.
This new service provides a fully integrated, end-to-end system combining U.S.-based peptide sourcing, compliant fulfillment, cold storage logistics, and…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
